Smiths Medical Recalls Certain CADD System Administration Sets and Cassette Reservoirs for Issues Causing Delay, Interruption, or Under-Delivery of Therapy Smi
Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant
Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination Global Pharma Healthcare is v
Trodelvy
FDA Approves Trodelvy (sacituzumab govitecan-hziy)for patients with specific metastatic hormone recepter breast cancers having received endocrine-based therapy
Jesduvroq
FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis The U.S. Food and Drug Administration approved Jesduvro
Orserdu
The Menarini Group, a leading Italian pharmaceutical and diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved Orserd
Jaypirca™
Jaypirca (pirtobrutinib) approved for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma Loxo@Lilly, the oncology unit of Eli Lilly and Company an
Brukinsa
Brukinsa (zanubrutinib) Approved in the U.S. for Chronic Lymphocytic Leukemia The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), manuf
Brenzavvy
FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes January 23, 2023 - TheracosBio has announced that the U.S. Food and Dru
Tukysa
FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colore
Adacel
FDA Approves Adacel for Immunization During Pregnancy to Help Protect Young Infants Against Pertussis The U.S. Food and Drug Administration (FDA) has approved
Rykindo
FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder Luye Pharma Group (Luye Pha
Rybelsus®
FDA Approves use of Rybelsus (semaglutide) as a First-Line Option for Adults with Type 2 Diabetes The FDA has approved a label update for Rybelsus (semaglutide
Compliance
Compliance West Virginia PBM NADAC Reporting WV NADAC Report_2024Q1WV NADAC Report_2024Q2WV NADAC Report_2024Q3WV NADAC Report_2024Q4WV NADAC Report_2025Q
Testimonials and Case Studies
"Benecard is the Pharmacy Benefit Manager (PBM) our clients choose to utilize when it comes t
HIPAA Privacy Statement
HIPAA Privacy Statement THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLE
NextRx Landing Page
Introducing Benecard NextRx Bringing Accountability to Prescription Benefits ...Guaranteed. Overall